GlassScriptPhysician profile
David S Miller
NPI 1417055369
$5,974.43
in general payments reported to CMS, 2019-2025
19 companies · $586 in 2025
The $586 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,256 · 2022: $394 · 2024: $1,739 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,541 · Food and Beverage: $716 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,540.83 |
| Food and Beverage | $716.11 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $3,380.79 | 2021-2022 | |
| Medtronic, INC. | $1,708.07 | 2024-2025 | Interstim |
| Astellas Pharma US INC | $154.95 | 2021 | |
| Janssen Biotech, INC. | $152.11 | 2025 | Erleada, Rybrevant, Carvykti |
| Procept Biorobotics Corporation | $149.53 | 2025 | |
| Calyxo, INC. | $57.87 | 2024-2025 | Cvac Aspiration System |
| Antares Pharma, INC. | $50.00 | 2022 | |
| Endo USA, INC. | $48.86 | 2025 | Xiaflex, Aveed |
| Boston Scientific Corporation | $39.15 | 2021 | |
| Sumitomo Pharma America, INC. | $37.36 | 2025 | Orgovyx |
| Astrazeneca Pharmaceuticals LP | $32.28 | 2025 | Lynparza |
| Progenics Pharmaceuticals, INC. | $25.85 | 2025 | |
| Laborie Medical Technologies Corp. | $25.01 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Acerus Pharmaceuticals Corporation | $24.60 | 2021 | |
| Immunitybio, INC. | $22.05 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Profound Medical Corp. | $19.15 | 2025 | Tulsa-Pro |
| Abbvie INC. | $16.36 | 2025 | |
| 180 Medical, INC. | $15.34 | 2024 | |
| Angiodynamics, INC. | $15.10 | 2025 | Nanoknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.